The glutamate homeostasis hypothesis of addiction
The DOI matches its Crossref record; 150 of the 151 references it cites were found in a registry or an index.
Abstract
Addiction is associated with neuroplasticity in the corticostriatal brain circuitry that is important for guiding adaptive behaviour. The hierarchy of corticostriatal information processing that normally permits the prefrontal cortex to regulate reinforcement-seeking behaviours is impaired by chronic drug use. A failure of the prefrontal cortex to control drug-seeking behaviours can be linked to an enduring imbalance between synaptic and non-synaptic glutamate, termed glutamate homeostasis. The imbalance in glutamate homeostasis engenders changes in neuroplasticity that impair communication between the prefrontal cortex and the nucleus accumbens. Some of these pathological changes are amenable to new glutamate- and neuroplasticity-based pharmacotherapies for treating addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key synaptic changes involve glutamate-modulated N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in glutamatergic projections from the prefrontal cortex and amygdala to the ventral tegmental area and nucleus accumbens (table 2, circuit 4).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [32]
In the citing paper
“Associations with SmkInit highlighted structures and functions related to long-term potentiation and reward-related learning and memory, systems that affect reward processing and addiction28,34,35.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“DLG4 affects NMDA receptors and potassium channel clusters, and plays a central role in glutamatergic models of reward-related learning35.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“which affects addictive behavior in mice35,36 and regulates glutamate metabotropic receptor 1 (GRM1).”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“According to the results of animal studies, glutamatergic projections from prefrontal cortex and from amygdala into VTA/SN and NAc mediate these conditioned responses (Kalivas 2009).”
From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Kalivas 2009
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“The anatomical and functional hierarchy of projections from the cortex to the basal ganglia is well characterize”
BackgroundThe neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 1×
“A corticostriatal circuitry of addiction A common perspective on addiction is that, with repeated drug use, drug-seeking behaviours become more habitual and less amenable to regulation by environmental contingencies, a viewpoint developed in recent review”
BackgroundDopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“Accordingly, the release of dopamine by addictive drugs is important for progressively shaping drug use into drug-seeking behaviours that are difficult to contro”
BackgroundGoldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647 · cited 1×
“Changes in the level or activity state of proteins after chronic drug administration have been intensively researched; for excellent reviews describing drug effects on transcriptional regulators and cell signalling proteins, see Ref”
BackgroundThe role of the basal ganglia in habit formation
Yin, H. H., & Knowlton, B. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1919 · Cited by 2,402 · cited 1×
“Corticostriatal projections are responsible not only for generating learnt, well-established behaviours such as in drug taking, but also for changing behaviours in response to a variable environment, and thereby generating new adaptive behaviour”
Background
Cited by
Items 801–900 of 1,000
Viral vector-mediated gene therapy for opioid use disorders
Wang, T., Zhu, X., Yi, H., Gu, J., Liu, S., Izenwasser, S., Lemmon, V., Roy, S., & Hao, S. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113710 · Cited by 12
Naim‐Feil, J., Fitzgerald, P. B., Rubinson, M., Lubman, D. I., Sheppard, D. M., Bradshaw, J. L., Levit‐Binnun, N., & Moses, E. (2022) · Addiction Biology · doi:10.1111/adb.13146 · Cited by 13
Pitchers, K. K., Sebastiano, A. R. D., & Coolen, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.002 · Cited by 13
Sathler, M. F., Stutz, B., Martins, R. S., Pereira, M. D. S., Pecinalli, N. R., Santos, L. E., Taveira‐da‐Silva, R., Lowe, J., de Freitas, I. G., Reis, R. A. D. M., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.022 · Cited by 12
“Yet, the complex spectrum of behavioral and neurochemical changes associated with drug abuse and dependence cannot be fully explained via dopaminemediated mechanisms alone (Kalivas, 2009).”
InfluentialDuncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
Reyes, B. A. S., Carvalho, A. F., Szot, P., Kalamarides, D. J., Wang, Q., Kirby, L. G., & Bockstaele, E. J. V. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.010 · Cited by 14
Drug Abuse and the Simplest Neurotransmitter
Kreple, C. J., Lü, Y., LaLumiere, R. T., & Wemmie, J. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500154w · Cited by 12
N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis
Winterlind, E. L., Malone, S. G., Setzer, M. R., Murphy, M. A., Saunders, D., & Gray, J. C. (2024) · Addiction Biology · doi:10.1111/adb.70001 · Cited by 11
Rangel‐Barajas, C., Coronel, I., Zhang, Y., Hernández, M., & Boehm, S. L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108339 · Cited by 11
“…enhances glutamatergic plasticity and excitotoxicity (Joffe et al., 2018; Blaker et al., 2019) accompanied with dysregulation of glutamate homeostasis, which is driven by disrupted expression of synaptic and non-synaptic glutamate transporters in alcohol abuse (Gass and Olive, 2008; Kalivas, 2009).”
BackgroundUnbiased Metabolomics Links Fatty Acid Pathways to Psychiatric Symptoms in People Living with HIV
Meeder, E. M. G., Matzaraki, V., Vadaq, N., de Wijer, L. V., van der Ven, A. J. A. M., & Schellekens, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235466 · Cited by 11
Becchi, S., Hood, J., Kendig, M. D., Mohammadkhani, A., Shipman, M. L., Balleine, B. W., Borgland, S. L., & Corbit, L. H. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06223-4 · Cited by 12
“Imbalance in extrasynaptic and synaptic glutamate (termed glutamate homeostasis) is hypothesized to contribute to vulnerability to addiction to drugs (Kalivas 2009; Scofield et al. 2016) and may similarly contribute to diet-induced behavioural impairments.”
BackgroundGupta, S. C., Ghobbeh, A., Taugher, R. J., Fan, R., Hardie, J. B., LaLumiere, R. T., & Wemmie, J. A. (2022) · Science Advances · doi:10.1126/sciadv.abq5058 · Cited by 12
Fernández‐Rodríguez, S., Cano-Cebrián, M. J., Esposito-Zapero, C., Pérez, S., Guerri, C., Zornoza, T., & Polache, A. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06311-z · Cited by 11
“Although a wealth of studies has highlighted the role of glutamate 1 3 homeostasis in relapse (Kalivas 2009) in the last decades, research has started to identify alterations in neuroimmune signalling associated with addiction-related behaviours, including relapse (Knapp et al.”
BackgroundInfluentialTran, T. D. B., Hernandez, C. M., Nguyen, H. T., Wright, S., Tarantino, L. M., Chesler, E. J., Weinstock, G. M., Zhou, Y., & Bubier, J. A. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12845 · Cited by 11
“supports the glutamate hypothesis of addiction [39-41], but now extends that process into the gut.”
BackgroundClavulanic Acid and its Potential Therapeutic Effects on the Central Nervous System
Balcazar-Ochoa, L. G., Ventura‐Martínez, R., López, G. E. Á., Acevedo, C. G., Carrasco, O. F., Sampieri-Cabrera, R., Chavarría, A., & González‐Hernández, A. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102916 · Cited by 12
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379156 · Cited by 11
Murakami, G., Nakamura, M., Takita, M., Ishida, Y., Ueki, T., & Nakahara, D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.115 · Cited by 12
“As mentioned above, one of most important features of glial function is to control extracellular levels of GLU by release (Baker et al, 2002; Kalivas, 2009) and uptake (Danbolt, 2001) mechanisms to maintain optimal synaptic transmission under physiological conditions.”
BackgroundQuintanilla, M. E., Morales, P., Ezquer, F. E., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.617418 · Cited by 13
“, 2020) disrupt glutamate homeostasis by impairing glutamate transport in areas involved in the brain reward system, increasing the relapse-promoting effect of drugrelated cues, thus sustaining drug craving and subsequent drug consumption (Kalivas, 2009).”
BackgroundInfluentialDrug addiction co-morbidity with alcohol: Neurobiological insights
McGinn, M. A., Pantazis, C. B., Tunstall, B. J., Marchette, R. C. N., Carlson, E. R., Said, N., Koob, G. F., & Vendruscolo, L. F. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.002 · Cited by 12
Angarita, G. A., Hadizadeh, H., Cerdena, I. L., & Potenza, M. N. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1931684 · Cited by 11
Fede, S. J., Kisner, M. A., Manuweera, T., Kerich, M., & Momenan, R. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac028 · Cited by 13
Zimmermann, J., Zoelch, N., Coray, R. C., Bavato, F., Friedli, N., Baumgartner, M. R., Steuer, A. E., Opitz, A., Werner, A., Oeltzschner, G., et al. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad023 · Cited by 12
“Additionally, the striatum and ACC are key loci for the initiation and maintenance of substance use, specifically linked to glutamatergic and GABAergic signaling, respectively (Kalivas, 2009; Koob and Volkow, 2016).”
Conventional Concepts and New Perspectives for Understanding the Addictive Properties of Inhalants
Duncan, J. R., & Lawrence, A. J. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r04cp · Cited by 11
Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
Hanganu, A., Degroot, C., Monchi, O., Bedetti, C., Mejia‐Constain, B., Lafontaine, A., Chouinard, S., & Bruneau, M. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00188 · Cited by 15
Garcia, E. J., & Cain, M. E. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172907 · Cited by 11
“homeostasis and increases drug-seeking (Kalivas 2009).”
BackgroundHervig, M. E.-S., Piilgaard, L., Božič, T., Alsiö, J., & Robbins, T. W. (2020) · Psychology & Neuroscience · doi:10.1037/pne0000221 · Cited by 11
“DHK-induced excess glutamate in the mOFC likely disturbs the finely tuned glutamate homeostasis required for optimal neuronal functioning in learning and plasticity (Kalivas, 2009), in turn disrupting synchronized neuronal firing (Gray, 1994).”
BackgroundManz, K. M., Zepeda, J. C., Zurawski, Z., Hamm, H. E., & Grueter, B. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1165261 · Cited by 10
“from assorted corticolimbic structures (Kalivas, 2009).”
BackgroundMavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial
Gomez‐Mancilla, B., Dürsteler, K. M., Vogel, M., Herdener, M., Torrens, M., Gálvez, B. P., Gual, A., Corral, R. M., Kuper, E., Mosca, D., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adi4505 · Cited by 11
Moccia, L., TOFANI, A., Mazza, M., Covino, M., Martinotti, G., Schifano, F., Janiri, L., & Nicola, M. D. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1578444 · Cited by 11
“(b, c, d): respectively axial, coronal, and sagittal views of a PET scan where a bilateral lower FDG uptake is evident in DLPFC, as indicated by red arrows. been postulated to underlie the neurobiological mechanisms of addiction (Kalivas 2009).”
BackgroundGreenberg, N., Farhadi, F., Kazer, B., Potenza, M., & Angarita, G. (2022) · Current Addiction Report · doi:10.1007/s40429-022-00446-3 · Cited by 6
IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice
Li, G., Yue, S., Wang, Y., Singh, A. K., & Wang, Z. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad013 · Cited by 10
“…transmission and/ or synaptic plasticity in the mesocorticolimbic system play an important role in the neuronal adaptations underlying the long-lasting behavioral plasticity induced by drugs, especially for psychostimulants such as cocaine (Wolf, 1998; Kalivas, 2009; Wolf and Ferrario, 2010).”
Chemogenetic manipulation of astrocyte activity at the synapse— a gateway to manage brain disease
Pereira, M. J., Ayana, R., Holt, M. G., & Arckens, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1193130 · Cited by 11
“When combined with a reduced basal level of signalling, this acts to ‘hyperactivate’ the system, and it is this enhanced level of glutamatergic signalling which has been proposed to increase susceptibility to continuous relapses (Kalivas, 2009).”
BackgroundEngeli, E., Russo, A. G., Ponticorvo, S., Zoelch, N., Hock, A., Hulka, L. M., Kirschner, M., Preller, K. H., Seifritz, E., Quednow, B. B., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103490 · Cited by 11
“Nonetheless, animal models of addiction consistently describe the cue-induced over-stimulation of the PFC-NAcc pathway as consequential to an overflow of glutamate in the NAcc and critical for cocaine-seeking (for overview see (Kalivas, 2009; Scofield et al., 2016)).”
InfluentialNamba, M. D., Xie, Q., & Barker, J. M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.021 · Cited by 10
Ketamine in Substance Use Disorder Treatment: A Narrative Review
Famuła, A., Radoszewski, J., Czerwiec, T., Sobiś, J., & Więckiewicz, G. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.241522 · Cited by 10
“44,45 Ketamine most likely influences synaptogenesis through NMDA receptor antagonism, leading to the synthesis of relevant proteins and the insertion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropioni (AMPA) receptors, 46 therefore, ketamine reverses the changes in glutamatergic transmission that…”
BackgroundNicotine is an Immunosuppressant: Implications for Women's Health and Disease
White, A. M., Craig, A. J., Richie, D. L., Corley, C. L., Sadek, S. M., Barton, H. N., & Gipson, C. D. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578468 · Cited by 11
Emerging roles of system antiporter and its inhibition in CNS disorders
Patel, D., Kharkar, P. S., & Nandave, M. (2015) · Molecular Membrane Biology · doi:10.3109/09687688.2015.1096972 · Cited by 11
Microelectrode Array Fabrication and Optimization for Selective Neurochemical Detection
Hascup, K. N., Hascup, E. R., Littrell, O. M., Hinzman, J. M., Werner, C. E., Davis, V. A., Burmeister, J. J., Pomerleau, F., Quintero, J. E., Huettl, P. F., et al. (2013) · Neuromethods · doi:10.1007/978-1-62703-370-1_2 · Cited by 13
Cerebral Metabolites on the Descending Limb of Acute Alcohol: A Preliminary 1H MRS Study
Monnig, M. A., Woods, A. J., Walsh, E. G., Martone, C. M., Blumenthal, J., Monti, P. M., & Cohen, R. A. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz062 · Cited by 10
“Glutamate may function as a mediator both of neuroinflammatory response and of mesolimbic dopaminergic activation (Kalivas, 2009; Crews et al., 2015).”
BackgroundGalduróz, J. C. F., Bezerra, A. G., Pires, G. N., Pauluci, R., & Noto, A. R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200128120729 · Cited by 10
Chen, T., Tan, H., Lei, H., Li, X., Wu, Q., Xu, X., Ye, Y., Zhong, N., Du, J., Jiang, H., et al. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111329 · Cited by 10
Involvement of Hippocampal Astrocytic Connexin-43 in Morphine dependence
Darvishmolla, M., Heysieattalab, S., Saeedi, N., Hosseinmardi, N., & Janahmadi, M. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113710 · Cited by 10
Yu, Q., Guo, X., Zhu, Z., Chen, F., Jiang, H., Zheng, Z., Zhang, J., Zhu, J., & Wu, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.806916 · Cited by 13
“The afferents to the NAcc are glutamatergic from the PFC, hippocampus, and amygdala, which excites neurons of the NAcc to establish roles in the neurocircuitry of pleasure and reward (51).”
BackgroundSketriené, D., Battista, D., Lalert, L., Kraiwattanapirom, N., Thai, H. N., Leeboonngam, T., Knackstedt, L. A., Nithianantharajah, J., Sumithran, P., Lawrence, A. J., et al. (2022) · Addiction Biology · doi:10.1111/adb.13206 · Cited by 11
“The cystine-glutamate exchanger exports glutamate to maintain extra-synaptic levels of glutamate,(17) while the GLT1 transporter performs re-uptake.(18,19) Changes in expression of the cystine-glutamate exchanger catalytic subunit, xCT, as well as GLT1 have been implicated vulnerability to drug relapse and the transit…”
BackgroundCellular and molecular basis of drug addiction: The role of neuronal ensembles in addiction
Liu, X., Wang, F., Le, Q., & Ma, L. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102813 · Cited by 12
Yarosh, H. L., Meda, S. A., de Wit, H., Hart, A. B., & Pearlson, G. D. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3914-1 · Cited by 13
“Both acute DA and glutamate effects in rat brain, and the alteration of long-term potentiation via glutamatergic tone and metabotropic glutamate receptors are crucial to acute responses to psychostimulant drugs and addiction (Zhang et al. 2001, Kalivas 2009).”
Barker, J. M., Lench, D. H., & Chandler, L. J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4101-0 · Cited by 10
“Together with a larger literature implicating glutamate signaling in addiction in general (Kalivas 2009) and in alcohol use disorders (Olive 2009) in particular, these findings suggest that abnormalities in mGluR2/3 signaling arising from chronic alcohol exposure may drive impairments in adaptive…”
BackgroundLoïodice, S., McGhan, P., Gryshkova, V., Fleurance, R., Dardou, D., Hafidi, A., da Costa, A. N., & Durif, F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117714051 · Cited by 10
“In the nucleus accumbens (Nac), mGluR5 downregulation has been reported as a counter-adaptation related to cocaine exposure (Kalivas, 2009).”
BackgroundResultInfluentialGlutamate receptor interacting protein acts within the prefrontal cortex to blunt cocaine seeking
Wickens, M. M., Deutschmann, A. U., McGrath, A. G., Parikh, V., & Briand, L. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107672 · Cited by 10
“After extended drug exposure, deficits in accumbal glutamate reuptake lead to reduced plasticity associated with addiction (Kalivas, 2009).”
BackgroundRegnier, S. D., Lile, J. A., Rush, C. R., & Stoops, W. W. (2022) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.744 · Cited by 10
Wang, R., Chen, H.-J., Huang, C., Wang, J., Lee, T.-E., Lee, H.-Y., & Hung, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201408 · Cited by 10
Moro, F., Giannotti, G., Caffino, L., Marzo, C. M., Clemente, A. D., Fumagalli, F., & Cervo, L. (2019) · Addiction Biology · doi:10.1111/adb.12771 · Cited by 11
“Recent studies have highlighted that changes in glutamate (GLU) homeostasis in the circuitry from the prefrontal cortex (PFC) to the nucleus accumbens (Nacc) contribute to the reinstatement of drug‐seeking behavior.(7) In particular, cocaine and nicotine self‐ administration reduce the expression of the cystine/GLU ex…”
BackgroundCancela, L. M., Mongi‐Bragato, B., Avalos, M. P., & Bollati, F. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010385 · Cited by 12
“Cocaine increased dendritic spine density [382–386] Stress induced changes in total and mushroom spines and facilitation of cocaine intake [84,151,152,365,393,394] Stress-induced microglial remodeling, dendritic spine alterations, and stress-related behaviors [376]”
InfluentialShamabadi, A., Ahmadzade, A., Aqamolaei, A., Mortazavi, S. H., Hasanzadeh, A., & Akhondzadeh, S. (2022) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v17i3.9733 · Cited by 11
Roles of metabotropic glutamate receptor 8 in neuropsychiatric and neurological disorders
Mao, L., Mathur, N., Shah, K., & Wang, J. Q. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.10.003 · Cited by 9
Cumming, P. D., Caprioli, D., & Dalley, J. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01036.x · Cited by 11
“5-CSRTT, five choice serial reaction time task; 5-HT, 5-hydroxytryptamine; ADHD, attention deficit hyperactivity disorder; BP, binding potential; CBF, cerebral blood flow; CIT, 2b-carboxymethoxy-3b-(4-iodophenyl)tropane; DASB, N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine; DAT, dopamine transporter site; DMFP,…”
BackgroundInfluentialPediatric Bipolar Disorder: An issue for Child Welfare
Littrell, J. L., & Lyons, P. (2010) · Children and Youth Services Review · doi:10.1016/j.childyouth.2010.03.021 · Cited by 10
Neural Circuit Plasticity in Addiction
Anderson, E., & Hearing, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00004-x · Cited by 11
Hasan, H. A., Abdelhady, S., Haidar, M. A., Fakih, C., Hayek, S. E., Mondello, S., Kobeissy, F. H., & Shaito, A. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_13 · Cited by 9
Giacometti, L. L., & Barker, J. M. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146390 · Cited by 10
“…note, perturbation of the glutamate and dopamine systems within limbic corticostriatal circuits has been implicated in the etiology of substance use disorders and the development of cognitive impairments (Murphy et al., 1996; Kalivas, 2009; Olive, 2009; Floresco, 2013; Dauvermann et al., 2017).”
BackgroundYates, J. R., Horchar, M. J., Ellis, A. L., Kappesser, J. L., Mbambu, P., Sutphin, T. G., Dehner, D. S., Igwe, H. O., & Wright, M. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05664-z · Cited by 9
“Because the glutamatergic system has been implicated in disorders characterized by excessive risk (Kalivas 2009; Pettorruso et al. 2014), there is utility in studying the contribution of glutamatergic receptors to risky choice.”
BackgroundZhang, L.-Y., Kim, A. Y., & Cheer, J. F. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100022 · Cited by 9
“Taken together, enhanced fidelity of PFC to NAc core glutamatergic signaling, reinforced by depleted extracellular glutamate concentrations, are pathogenic markers of vulnerability to relapse-related behavior [34].”
BackgroundInfluentialHammad, A. M., Alzaghari, L. F., Alfaraj, M., Al-Qerem, W. A., Talib, W. H., Alasmari, F. F., Amawi, H. A., & Hall, F. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1047236 · Cited by 10
“Previous studies have shown that changes in glutamate homeostasis in the PFC and NAc contribute to the reinstatement of drug-seeking behavior (Kalivas, 2009).”
BackgroundMethodInfluentialNon-Opioid Anesthetics Addiction: A Review of Current Situation and Mechanism
Deng, L., Wu, L., Gao, R., Xu, X., Chen, C., & Liu, J. (2023) · Brain Sciences · doi:10.3390/brainsci13091259 · Cited by 9
Esketamine Inhibits Cocaine-Seeking Behaviour Subsequent to Various Abstinence Conditions in Rats
Wydra, K., Witek, K., Suder, A., & Filip, M. (2023) · Biomolecules · doi:10.3390/biom13091411 · Cited by 9
“The findings also support the strong impact of glutamatergic (Glu) signalling over cocaine seeking and relapse [3].”
BackgroundNeurobiological mechanisms underlying psychostimulant use
Campbell, R. R., & Lobo, M. K. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102786 · Cited by 9
Nawarawong, N. N., & Olsen, C. M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112275 · Cited by 9
“As previously mentioned, the shift from recreational drug use to compulsive drug seeking may be driven by glutamate rather than dopamine [63].”
BackgroundWukitsch, T. J., Moser, T. J., Brase, E. C., Kiefer, S. W., & Cain, M. E. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.09.001 · Cited by 9
“Current theories of addiction explain that neurobiological adaptation and changes to systems involved in motivation result in addiction and substance use disorders (Berridge & Robinson, 2011, 2016; Kalivas, 2009; Robinson & Berridge, 1993, 2003; Solomon & Corbit, 1974).”
BackgroundRose, T. R., de Velasco, E. M. F., Vo, B. N., Tipps, M. E., & Wickman, K. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2606-20.2020 · Cited by 9
“For example, cocaine exposure increases glutamate release in the NAc and VTA (Kalivas, 2009), and these increases and associated cocaine-induced neuroadaptations and drugseeking behavior can be blocked by mPFC inactivation (Li et al., 1999; McFarland and Kalivas, 2001; McFarland et al., 2003; Steketee, 2003; Jo et al.…”
BackgroundMini review: Promotion of substance abuse in HIV patients: Biological mediation by HIV-1 Tat protein
Cirino, T. J., & McLaughlin, J. P. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135877 · Cited by 11
Effects of adenosine A2A receptor antagonists on cocaine-induced locomotion and cocaine seeking
Haynes, N. S., O’Neill, C. E., Hobson, B. D., & Bachtell, R. K. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5097-z · Cited by 9
“Here, multiple neurotransmitter systems interact during chronic cocaine administration and are thought to underlie many behavioral characteristics of addiction (Self et al. 2004; Kalivas 2009).”
BackgroundGao, Z., Winhusen, T. M., Gorenflo, M. P., Dorney, I., Ghitza, U. E., Kaelber, D. C., & Xu, R. (2024) · Addiction · doi:10.1111/add.16715 · Cited by 8
Ketamine’s Therapeutic Role in Substance Use Disorders: A Narrative Review
Thomas, A., & Chambers, R. A. (2025) · NeuroSci · doi:10.3390/neurosci6030083 · Cited by 9
Ulisse, K., Albitar, J., Aromin, J. T., & Berry, J. H. (2025) · Brain Sciences · doi:10.3390/brainsci15090980 · Cited by 9
“The withdrawal/negative affect stage follows chronic use, marked by dopaminergic downregulation, glutamate—Gamma-Aminobutyric Acid (GABA) imbalance, and recruitment of stress systems leading to anhedonia and dysphoria [3,6–8].”
Alotaibi, A., Bhowmik, K. K., Wong, W., Mohammed, A. S., Abou-Gharbia, M. A., Childers, W. E., & Sari, Y. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf075 · Cited by 8
Bahí, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.029 · Cited by 8
“A large amount of evidence suggests that targeting the mGluR system may be helpful in the treatment of addiction disorders in general and alcoholism in particular (Knackstedt and Kalivas, 2009; Olive, 2009).”
BackgroundRetractedEnrico, P., Migliore, M., Spiga, S., Mulas, G., Caboni, F., & Diana, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.006 · Cited by 8
“Aminoacidergic neurotransmission is profoundly involved in the physiology of VTA DA cells, as well as in the neurobiological basis of drug addiction (Tzschentke and Schmidt, 2003; Kalivas, 2009).”
BackgroundAlmalki, A. H., Naguib, I. A., Alshehri, F. S., Alghamdi, B. S. A., Alsaab, H. O., Althobaiti, Y. S., Alshehri, S., & Abdallah, F. F. (2021) · Molecules · doi:10.3390/molecules26185436 · Cited by 8
Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats
McLaurin, K. A., Li, H., Mactutus, C. F., Harrod, S. B., & Booze, R. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169100 · Cited by 8
“, [21–24]) and PFC [25]; alterations in glutamate homeostasis also develop (for review, [26]).”
BackgroundAvalos, M. P., Guzman, A. S., García‐Keller, C., Mongi‐Bragato, B., Esparza, M. A., Rigoni, D., Sanchez, M. A., Calfa, G. D., Bollati, F. A., & Cancela, L. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.896268 · Cited by 8
“By 120min, when extracellular glutamate levels were re-established, spine head diameter was significantly reduced, an event that apparently is coupled to a reduction of AMPARs (Boudreau et al., 2007; Kourrich et al., 2007; Kalivas, 2009).”
BackgroundResultInfluentialAbdullah, M., Lin, S., Huang, L.-C., Chen, P. S., Tseng, H., & Yang, Y. K. (2024) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2024.04.004 · Cited by 9
GABA system in the prefrontal cortex involved in psychostimulant addiction
Shi, W., Li, M., Zhang, T., Yang, C., Zhao, D., & Bai, J. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae319 · Cited by 8
Loïodice, S., Winlow, P., Dremier, S., Hanon, É., Dardou, D., Ouachikh, O., Hafidi, A., da Costa, A. N., & Durif, F. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4430-7 · Cited by 9
Wegener, A. J., & Neigh, G. N. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.780190 · Cited by 9
“This may not be surprising considering that canonical pathways dysregulated in these mood disorders include glutamate homeostasis and inflammation, both of which are tightly regulated by glial cells (Kalivas, 2009; Bilbo et al., 2012).”
BackgroundSubstance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 11
Lower dACC glutamate in cannabis users during early phase abstinence
Zuo, C. S., Davis, K. A., & Lukas, S. E. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01321-5 · Cited by 10
Robinson, K. J., Everett, N. A., Baracz, S. J., & Cornish, J. L. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06175-9 · Cited by 8
Associations between polygenic risk scores and accelerated brain ageing in smokers
Yang, Z., Zhao, W. D., Linli, Z., Guo, S., & Feng, J. (2023) · Psychological Medicine · doi:10.1017/s0033291723001812 · Cited by 8
“…to substances such as nicotine or morphine leads to sustained structural changes in the dendrites and dendritic spines on cells in brain regions involved in motivation and reward (e.g. the nucleus accumbens), judgment and inhibitory control of behavior (e.g. the prefrontal cortex) (Kalivas, 2009).”
BackgroundLighting up the brain's reward circuitry
Lobo, M. K. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06368.x · Cited by 8
Neural Basis of Drug Addiction
Gipson, C. D., & Kalivas, P. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-17795-3_4 · Cited by 11
“Additionally, Kalivas [7] postulates that the NA serves as a gateway in the transition from limbic to motor control in addiction.”
BackgroundSelf-citationKim, J. S., & Martin‐Fardon, R. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14264 · Cited by 8
“Involvement of the Medial Prefrontal Cortex in Drug Seeking The mPFC is a key component of the mesocorticolimbic system and has been implicated in the regulation of drug-taking behavior (Kalivas, 2008, 2009).”
BackgroundAmaral, V. C. S., Morais‐Silva, G., Laverde, C. F., & Marin, M. T. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.07.002 · Cited by 8
Vrettou, M., Yan, L., Nilsson, K. W., Wallén‐Mackenzie, Å., Nylander, I., & Comasco, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-94739-8 · Cited by 9
Dopamine neurotransmission in the VTA regulates aversive memory formation and persistence
Díaz, F. C., Dalto, J. F., Pereyra, M., & Medina, J. H. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113854 · Cited by 10
Quintanilla, M. E., Quezada, M., Morales, P., Berríos‐Cárcamo, P., Santapau, D., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02225-0 · Cited by 8
Laverde, C. F., Morais‐Silva, G., Amaral, V. C. S., & Marin, M. T. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000613 · Cited by 8
“Recently, an increasing amount of data has shown that these alterations are related to an imbalance between synaptic and extrasynaptic glutamate (Kalivas, 2009; Scofield et al., 2016; Scofield, 2018).”
BackgroundTavakoli, N. S., Malone, S. G., Anderson, T. L., Neeley, R. E., Asadipooya, A., Bardo, M. T., & Ortinski, P. I. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1347491 · Cited by 8
“…of Ca 2 + -dependent release of glutamate from astrocytes is intriguing, given the well-documented impact of glutamate on cocaine-seeking behavior (Kalivas, 2009; Knackstedt and Kalivas, 2009; Scofield et al., 2015), contribution of other astrocyte-secreted neurotransmitters, such as ATP or GABA…”
BackgroundSallie, S. N., Sonkusare, S., Mandali, A., Casero, V., Cui, H., Guzman, N. V., Allison, M. E., & Voon, V. (2023) · Psychological Medicine · doi:10.1017/s0033291723002374 · Cited by 9
“…models, acute administration promotes inhibitory processes (Abrahao et al., 2017), while chronic use leads to a compensatory increase in global cortical excitability via a reduction of GABAergic and concomitant upregulation of glutamatergic transmission and NMDA-receptor release (Kalivas, 2009).”
Wittenkeller, L. M., Gudelsky, G. A., Winhusen, T. M., & Amato, D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70181 · Cited by 10
“During withdrawal from chronic drug use, transcriptional, epigenetic (Robison & Nestler, 2011) and physiological (Bonci & Williams, 1997; Kalivas, 2009; Kruyer et al., 2019; Kruyer et al., 2022; Luscher & Malenka, 2011; Thomas et al., 2008) changes occur that result in persistent structural and…”
Introduction to the Neuropsychopharmacology of Drug Addiction
Koob, G. F., Arends, M. A., & Moal, M. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386937-1.00002-7 · Cited by 7
Metadata
- Authors
- Kalivas, P. W.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Kalivas, Peter W.
- ORCID
- Kalivas, Peter W.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-01
- Volume
- 10
- Issue
- 8
- Pages
- 561-572
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2021594631
- Semantic Scholar
- 926519bbbfc2dba348202b61755ab1bafbd520ae
- Cited by
- 1,350
- References
- 151
- Citations by year
- 2026: 42 · 2025: 70 · 2024: 66 · 2023: 61 · 2022: 89 · 2021: 81 · 2020: 107 · 2019: 96 · 2018: 71 · 2017: 77 · 2016: 93 · 2015: 81 · 2014: 73 · 2013: 97 · 2012: 84
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 015, DA 003, DA 012)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- glutamate homeostasis, addiction, prefrontal cortex, nucleus accumbens, corticostriatal circuits, dendritic spine morphology, synaptic plasticity, neuroplasticity, drug-seeking behavior
- MeSH terms
- Animals, Homeostasis, Humans, Models, Biological, Nerve Net, Neural Pathways, Nucleus Accumbens, Prefrontal Cortex, Glutamic Acid, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.